{ "name": "Dr. Max — Engaged Target (M6)", "slug": "drmax-validation-engaged-target", "configuration": { "L0": { "archetype": "Elevation", "board_state": "Aware", "multi_market": true, "mandate_scope": "GroupWide", "regulatory_profile": "High", "engagement_duration": "Standard6mo", "external_champion_org": "(formerly Deloitte / EmbedIT — Kateřina now internal Head of AI)", "internal_ai_lead_state": "SeniorUnderAuth", "ai_act_deadline_pressure": "Months_3_to_6", "external_champion_present": false, "pe_owner_engagement_level": "Active" }, "L1": {}, "L2": { "L2-201": { "verb": "Decide", "counterparties": [ "InitiativeLead-informed" ] }, "L2-202": { "verb": "Decide", "counterparties": [ "Leo Ferrandino (Sponsor)" ] }, "L2-203": { "verb": "Propose", "counterparties": [ "Thomas Bornemann (CFO)", "Leo Ferrandino (Sponsor)", "Miguel Martins da Silva (CSCO/OpsLead)" ] }, "L2-204": { "verb": "Decide", "counterparties": [ "Leo Ferrandino (Sponsor)-informed" ] }, "L2-205": { "verb": "Decide", "counterparties": [ "InitiativeLead-informed" ] }, "L2-206": { "verb": "Propose", "counterparties": [ "Leo Ferrandino (CEO)", "Thomas Bornemann (CFO)" ] }, "L2-207": { "verb": "Decide", "counterparties": [ "Thomas Bornemann (CFO)-monthly-informed" ] }, "L2-208": { "verb": "Propose", "counterparties": [ "Thomas Bornemann (CFO)", "Penta Operating Partner (Board)" ] } }, "L3": { "L3-301": "stood_up", "L3-302": "stood_up", "L3-303": "stood_up", "L3-304": "stood_up", "L3-305": "stood_up", "L3-306": "stood_up", "L3-307": "stood_up", "L3-308": "stood_up", "L3-309": "stood_up", "L3-310": "stood_up", "L3-311": "stood_up", "L3-312": "stood_up", "L3-313": "stood_up", "L3-314": "stood_up", "L3-315": "stood_up", "L3-316": "stood_up", "L3-317": "stood_up", "L3-318": "stood_up", "L3-319": "stood_up", "L3-320": "stood_up", "L3-321": "stood_up", "L3-322": "stood_up", "L3-323": "stood_up", "L3-324": "stood_up", "L3-325": "stood_up", "L3-326": "stood_up", "L3-327": "stood_up", "L3-328": "stood_up", "L3-329": "stood_up", "L3-330": "stood_up" }, "peers": { "CEO": { "named": true, "active": true }, "CFO": { "named": true, "active": true }, "CIO": { "named": true, "active": true }, "CRO": { "named": false, "active": false }, "DPO": { "named": true, "active": true }, "CMCO": { "named": true, "active": true }, "QMHead": { "named": true, "active": true }, "HeadOfAI": { "named": true, "active": true }, "ExternalChampion": { "named": false, "active": false }, "PEOperatingPartner": { "named": true, "active": true } }, "version": 1, "meta_charter": { "q4_escalation": { "upward": [ { "who": "Initiative team", "when": "Initiative-level blockers", "level": "L0", "cadence": "Continuous" }, { "who": "AI Council", "when": "Cross-initiative or cross-function blockers", "level": "L1", "cadence": "Bi-weekly" }, { "who": "Exec sponsor + CEO (Leonardo Ferrandino)", "when": "Authority denied; gate criteria slipping; risk-policy breach", "level": "L2", "cadence": "On-trigger (5 BD SLA)" }, { "who": "Board chair", "when": "Engagement integrity at risk; Partner-CEO disagreement on critical decision", "level": "L3", "cadence": "On-trigger (rare)" } ], "reverse": [ { "path": "→ Engagement sponsor → CEO", "when": "Partner conduct concern; Partner overstepping role; coaching quality issue", "initiator": "Internal AI Lead (Kateřina Lesch)" }, { "path": "→ CEO → Board chair", "when": "Partner conduct or commercial concern", "initiator": "Engagement sponsor" }, { "path": "→ Engagement sponsor", "when": "Cross-function impact concern", "initiator": "Any exec" }, { "path": "→ CEO", "when": "Strategic-direction concern", "initiator": "Board chair" } ], "recusal_sla_days": 5 }, "q7_commercial": { "delivery_layer": { "scope_ladder_explanation": "Must-have: workshops with Kateřina + C-suite, AI Act conformity scoping, BDN sessions per market. Should-have: PoC support, decision register stand-up, training. Nice-to-have: advanced analytics, vendor evaluation, deeper coaching. Capped at €120K; scope re-negotiated if exceeded.", "workshop_rate_eur_per_day": 2400, "indicative_envelope_max_eur": 120000, "indicative_envelope_min_eur": 60000 }, "pre_engagement": { "typical_fte_pct": 35, "indicative_total_eur": 35000, "chargeable_separately": true, "typical_duration_weeks_max": 8, "typical_duration_weeks_min": 6 }, "partner_day_rate": { "fte_pct": 25, "monthly_eur": 10000, "sponsor_role": "CEO (Leonardo Ferrandino) / engagement sponsor", "days_per_month": 5, "rate_eur_per_day": 2000, "six_month_total_eur": 60000 }, "recusal_protocol": { "sla_days": 5, "client_commercial_counterpart_role": "CFO (Thomas Bornemann) — owns VV commercial decisions when Partner is recused" }, "specialist_contractors": { "routing": "client-paid OR VV pass-through (transparent markup)", "description": "Data eng, MLOps, legal review, change management — on-demand" }, "exit_criteria_bonus_eur": 40000, "benefits_realization_packages_eur": [ 37500, 50000 ] }, "q5_partner_kpis": [ { "name": "Track maturity index (composite of 6 tracks)", "source": "Velocity checkpoint (platform)", "target": "Monotonically increasing", "cadence": "4-weekly" }, { "name": "% stable-without-us per track", "source": "Velocity checkpoint", "target": "Trending toward exit thresholds", "cadence": "4-weekly" }, { "name": "Pipeline depth (initiatives in each Track 1 stage)", "source": "Track 1 dashboard", "target": "Stage 4–5 ≥ 2× Stage 6 capacity", "cadence": "4-weekly" }, { "name": "Heavy-gate decision velocity", "source": "Heavy-gate logs", "target": "Decisions made within 1 cycle of readiness", "cadence": "Monthly" }, { "name": "Healthy kill rate", "source": "Track 1 dashboard", "target": "≥ 30% of initiatives killed before Pilot stage", "cadence": "Monthly" }, { "name": "Sponsor coverage on active pilots", "source": "J3 audit", "target": "100% of pilots have D2 sponsor", "cadence": "Continuous" }, { "name": "Risk-classified initiatives", "source": "Risk register", "target": "100% of Scoped+ have Track 5 classification", "cadence": "Continuous" }, { "name": "Decision register completeness", "source": "Decision register audit", "target": "≥ 95% of named decisions logged within 5 BD", "cadence": "Weekly" } ], "q1_mandate_scope": { "type": "MethodologyCentralExecutionDistributed", "explanation": "Multi-market engagement (CZ/SK/PL/HU/RO/BG). Methodology + standards set centrally by Partner; markets execute within that frame. Default per §8.1 for multi-market groups.", "multi_market_split": { "group_level_decisions": [ "4-Gate framework + portfolio rules", "AI risk policies + EU AI Act conformity standard", "Platform standards (data, MLOps, vendor)", "Heavy Gate 2 (Pilot-Validated → Scaling)", "Group-level AI Council membership", "Annual AI envelope-setting (proposal)" ], "market_level_decisions": [ "Local AI initiative kickoff (within group standards)", "Local market-specific PoC sponsorship", "Local regulatory engagement (within group framework)", "Local champion induction", "Per-market DPIA approval (under group template)" ] } }, "q2_authority_set": { "must_have_l1_ids": [ "L1-101", "L1-102", "L1-103", "L1-104", "L1-106", "L1-107", "L1-108", "L1-110", "L1-111", "L1-112", "L1-113", "L1-116", "L1-117", "L1-121", "L1-124", "L1-125", "L1-129" ], "explicitly_recused": [ "L1-132 — Approve VV scope expansion (commercial conflict; recused per §1.3 invariant #5 and §8.7)" ], "nice_to_have_l1_ids": [ "L1-105", "L1-109", "L1-114", "L1-118", "L1-126", "L1-130" ], "out_of_scope_l1_ids": [ "L1-115", "L1-119", "L1-120", "L1-127", "L1-128", "L1-131" ] }, "q6_exit_criteria": { "hard_criteria": [ { "id": "EX-H-1", "satisfied": null, "description": "Internal AI Lead (Kateřina) in confirmed seat with full mandate" }, { "id": "EX-H-2", "satisfied": null, "description": "AI Council operating ≥ 2 cycles autonomously (Track 3 ≥ Level 5)" }, { "id": "EX-H-3", "satisfied": null, "description": "One full Heavy Gate cycle without Partner intervention" }, { "id": "EX-H-4", "satisfied": null, "description": "Risk & Compliance ≥ Level 4 (High regulatory profile + multi-market floor); live monitoring evidence ≥ 1 quarter" }, { "id": "EX-H-5", "satisfied": null, "description": "Track 6 ≥ Level 3 (P&L-linked) — requires Track 3 Level 4 first per §6 coupling" }, { "id": "EX-H-6", "satisfied": null, "description": "Internal AI Lead self-rates readiness ≥ 7/10" }, { "id": "EX-H-7", "satisfied": null, "description": "Board has held ≥ 2 board-grade reviews" }, { "id": "EX-H-8", "satisfied": null, "description": "Engagement Charter handover pack delivered + signed" } ], "soft_criteria": [ { "id": "EX-S-1", "satisfied": null, "description": "Pipeline at healthy depth (Stage 4–5 stocks adequate)" }, { "id": "EX-S-2", "satisfied": null, "description": "≥ 2 initiatives in BAU with measured benefits" }, { "id": "EX-S-3", "satisfied": null, "description": "Champion stock ≥ pilot demand" }, { "id": "EX-S-4", "satisfied": null, "description": "Value Chain Coverage ≥ Level 3 (group-level; per-market Level 1–2 acceptable)" }, { "id": "EX-S-5", "satisfied": null, "description": "Track maturity index above floor on every track" } ], "regulatory_profile_override": "High (pharma + multi-market): Track 5 floor lifted to Level 4. Highest market sets the floor — cannot exit below the strictest market regulatory requirements.", "multi_market_floor_rule_active": true }, "q3_decision_rights": { "decide": [ "4-Gate methodology choices + gate weights", "AI Council operating mechanics (cadence, agenda, chair rotation)", "Recusal protocol triggers + adjudication routing", "Methodology pacing per track" ], "propose": [ "L2-202 Advance to Pilot (Gate 1) — proposes; CEO/sponsor decides", "L2-203 Advance to Scale (Gate 2) — proposes; Scale Decision Forum decides", "L2-209 Internal AI Lead role design — proposes; CEO + HR decide", "L2-211 AI function specialist hires — proposes; HR + IAL decide", "Annual AI envelope sizing — proposes; CEO/board approves", "Vendor portfolio composition — proposes; procurement + CIO decide" ], "recused": [ "VV commercial scope expansion", "Engagement contract renewal pricing", "VV consultant assignment to specific deliverables" ], "recommend": [ "Strategic pivots affecting AI scope", "Reorganizations adjacent to AI function", "External regulator engagement (when Partner not authorized to speak)" ], "market_level_decisions": [ "Per-market initiative kickoff (within group standards)", "Per-market sponsor pairing", "Per-market DPIA approval (under group template)" ] }, "q8_peer_interfaces": [ { "role": "CEO", "market": null, "pattern": "Sponsor; engagement integrity owner", "owned_issues": [ "Mandate", "Authority denials", "Exec coaching" ], "conflict_prone_areas": [ "If CEO is also primary sponsor, recusal protocol critical (no overlap with Q7 commercial decisions)" ] }, { "role": "CFO", "market": null, "pattern": "Co-decider on benefits, capex, business cases. Adjudicates VV commercial when Partner recused.", "owned_issues": [ "Track 6 (Value & Reporting)", "Heavy Gate 2 capex", "Advisory-tail commercial", "VV scope decisions when Partner recused" ], "conflict_prone_areas": [ "Attribution disputes on benefits" ] }, { "role": "CIO", "market": null, "pattern": "Peer; tech-platform partnership; likely reporting line for IAL (Kateřina)", "owned_issues": [ "Tooling integration", "MLOps", "Security overlap", "IAL reporting line" ], "conflict_prone_areas": [ "Vendor selection overlap", "Non-AI tech veto-overlap" ] }, { "role": "CRO/CISO", "market": null, "pattern": "Co-owner of Track 5 (Risk & Compliance). Distributed at Dr Max — pharmacovigilance / QM / DPO / ESG / Supervisory Board.", "owned_issues": [ "Risk classification", "AI Act compliance", "Incident response" ], "conflict_prone_areas": [ "Pace of policy rollout vs. pace of pilots" ] }, { "role": "CMCO", "market": null, "pattern": "Peer; potential AI sponsor for customer-facing initiatives (Benefit Card, e-shop, marketplace)", "owned_issues": [ "Customer data", "Loyalty data foundation (5b)", "Personalization use cases" ], "conflict_prone_areas": [ "Privacy vs. personalization tradeoffs" ] }, { "role": "CSCO", "market": null, "pattern": "Peer; ALREADY AI-active (VusionGroup, Geek+, Rinkai, dark warehouse). Senior champion role.", "owned_issues": [ "Supply chain AI", "Multi-market store digitalization", "Existing vendor relationships" ], "conflict_prone_areas": [ "Existing vendor commitments vs group-level vendor portfolio governance" ] }, { "role": "HeadM&A", "market": null, "pattern": "Peer; continuous M&A pipeline (Žalfija + ongoing). Post-acquisition AI integration relevant.", "owned_issues": [ "M&A AI integration template (L3-330)" ], "conflict_prone_areas": [ "Post-acquisition autonomy vs group standardization" ] }, { "role": "DPO (group-level)", "market": null, "pattern": "Co-owner of data privacy posture; convenes multi-DPO Council with Internal AI Lead", "owned_issues": [ "Multi-DPO coordination protocol (M-DPO mechanism)", "Cross-border transfers", "Common DPIA template" ], "conflict_prone_areas": [ "Cross-border or multi-jurisdiction conflicts" ] }, { "role": "DPO (per-market)", "market": "CZ", "pattern": "Co-owner of data privacy posture for CZ market — likely lead DPO given Dr Max group HQ", "owned_issues": [ "CZ DPIA approvals", "Czech ÚOOÚ engagement" ], "conflict_prone_areas": [] }, { "role": "DPO (per-market)", "market": "SK", "pattern": "Co-owner of data privacy posture for SK market", "owned_issues": [ "SK DPIA approvals", "Slovak ÚOOÚ engagement" ], "conflict_prone_areas": [] }, { "role": "DPO (per-market)", "market": "PL", "pattern": "Co-owner of data privacy posture for PL market", "owned_issues": [ "PL DPIA approvals", "Polish UODO engagement" ], "conflict_prone_areas": [] }, { "role": "PE Operating Partner (Penta)", "market": null, "pattern": "Stakeholder; Heavy Gate 2 counterparty for capex commits. UNKNOWN identity — open question.", "owned_issues": [ "Capex sign-off above threshold", "Strategic alignment with Penta thesis" ], "conflict_prone_areas": [ "Speed vs governance tradeoffs typical of PE" ] }, { "role": "Board chair", "market": null, "pattern": "Escalation L3; board literacy partner", "owned_issues": [ "Board AI literacy", "Sponsorship coaching" ], "conflict_prone_areas": [ "When CEO ↔ board chair disagree" ] } ] }, "delivery_state": {}, "track_baselines": { "source": "Methodology v0.4 §10 (Dr Max application read)", "target": [ { "notes": "2 cycles of gates without Partner intervention", "track_id": 1, "level_or_stage": "≥ 80% stable-without-us" }, { "notes": "Champion induction + sponsor pairing operational", "track_id": 2, "level_or_stage": "A2 ≥60%; B-stock ≥ pilot demand; D2 100%" }, { "notes": "Internal AI Lead chairs without Partner; ≥ 2 cycles autonomous", "track_id": 3, "level_or_stage": "Level ≥ 5 (Self-running)" }, { "notes": "Depth achieved on group; market customization allowed", "track_id": 4, "level_or_stage": "Level ≥ 3 (group); Level 1–2 per-market acceptable" }, { "notes": "High regulatory + multi-market = floor at L4; live monitoring + DPIA on file + ISO 42001 readiness pack", "track_id": 5, "level_or_stage": "Level ≥ 4 (Monitored)" }, { "notes": "CFO sign-off on benefits framework; board pack rhythm", "track_id": 6, "level_or_stage": "Level ≥ 3 (P&L-linked); Level 4 strongly preferred" } ], "current": [ { "notes": "Drain existing initiative list through 4-Gate Week 1", "track_id": 1, "level_or_stage": "Stage 1–2 (Captured exists, no flow)" }, { "notes": "Group + per-market champion mapping needed", "track_id": 2, "level_or_stage": "A1 thin, B0–1 embryonic, C partial, D mixed" }, { "notes": "Group-vs-market authority must be settled first", "track_id": 3, "level_or_stage": "Level 0–1 (Absent / Chartered)" }, { "notes": "Multi-market: group-level Level 3 target + per-market Level 1–2", "track_id": 4, "level_or_stage": "Level 0–1 (Reactive / Anchor mapped)" }, { "notes": "EU AI Act + GDPR + health + loyalty data → need Level 2 by mid-engagement", "track_id": 5, "level_or_stage": "Level 1 (Classified — some classification likely exists)" }, { "notes": "Board-pack rhythm earlier than default given Dr Max board engagement", "track_id": 6, "level_or_stage": "Level 0 (Opaque)" } ] }, "engagement_phase": "M1-M6", "design_invariants": { "clean_commercial_interface": { "notes": "3-layer fee structure drafted (Q7); recusal SLA 5 BD; CFO Bornemann named as commercial counterpart when Partner recused. Pending charter signature.", "satisfied": null }, "exit_criteria_agreed_upfront": { "notes": "8 hard + 5 soft criteria drafted (Q6); pending sign-off at M0.", "satisfied": null }, "successor_building_from_day_1": { "notes": "Internal AI Lead (Kateřina) named, internal, named+active. Authority Erosion × Elevation counter-mechanisms required throughout (visibility-elevation rituals; attribution discipline; recusal on Lead's domain decisions).", "satisfied": true }, "system_setter_not_daily_decider": { "notes": "Partner role = Michal as Interim CAIO + VV delivery. Standing recusal on commercial framing.", "satisfied": null }, "real_authority_fractional_presence": { "notes": "Mandate scope (Q1) drafted; authority asks (Q2) listed; pending charter signature at M0.", "satisfied": null } } }, "exportedAt": "2026-09-02T19:10:30.281Z" }